Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
In most myogenic systems, synthesis of the intermediate filament (IF) protein vimentin precedes the synthesis of the muscle-specific IF protein desmin. In the dorsal myotome of the Xenopus embryo, however, there is no preexisting vimentin filament system and desmin's initial organization is quite different from that seen in vimentin-containing myocytes (Cary and Klymkowsky, 1994. Differentiation. In press.). To determine whether the organization of IFs in the Xenopus myotome reflects features unique to Xenopus or is due to specific properties of desmin, we used the injection of plasmid DNA to drive the synthesis of vimentin or desmin in myotomal cells. At low levels of accumulation, exogenous vimentin and desmin both enter into the endogenous desmin system of the myotomal cell. At higher levels exogenous vimentin forms longitudinal IF systems similar to those seen in vimentin-expressing myogenic systems and massive IF bundles. Exogenous desmin, on the other hand, formed a reticular IF meshwork and non-filamentous aggregates. In embryonic epithelial cells, both vimentin and desmin formed extended IF networks. Vimentin and desmin differ most dramatically in their NH2-terminal "head" regions. To determine whether the head region was responsible for the differences in the behavior of these two proteins, we constructed plasmids encoding chimeric proteins in which the head of one was attached to the body of the other. In muscle, the vimentin head-desmin body (VDD) polypeptide formed longitudinal IFs and massive IF bundles like vimentin. The desmin head-vimentin body (DVV) polypeptide, on the other hand, formed IF meshworks and non-filamentous structures like desmin. In embryonic epithelial cells DVV formed a discrete filament network while VDD did not. Based on the behavior of these chimeric proteins, we conclude that the head domains of vimentin and desmin are structurally distinct and not interchangeable, and that the head domain of desmin is largely responsible for desmin's muscle-specific behaviors.
Bennett,
Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro.
1979, Pubmed
Bennett,
Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro.
1979,
Pubmed
Blessing,
Ectopic synthesis of epidermal cytokeratins in pancreatic islet cells of transgenic mice interferes with cytoskeletal order and insulin production.
1993,
Pubmed
Brady,
Passive stiffness of rat cardiac myocytes.
1984,
Pubmed
Capetanaki,
Overexpression of the vimentin gene in transgenic mice inhibits normal lens cell differentiation.
1989,
Pubmed
Cary,
Desmin organization during the differentiation of the dorsal myotome in Xenopus laevis.
1994,
Pubmed
,
Xenbase
Ching,
Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments.
1993,
Pubmed
Christian,
Overexpression of wild-type and dominant negative mutant vimentin subunits in developing Xenopus embryos.
1990,
Pubmed
,
Xenbase
Cossette,
Expression of a developmentally regulated cross-linking intermediate filament-associated protein (IFAPa-400) during the replacement of vimentin for desmin in muscle cell differentiation.
1991,
Pubmed
Côté,
Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis.
1993,
Pubmed
Craig,
Gamma actin, spectrin, and intermediate filament proteins colocalize with vinculin at costameres, myofibril-to-sarcolemma attachment sites.
1983,
Pubmed
Cross,
Cytoskeletal actin gene families of Xenopus borealis and Xenopus laevis.
1988,
Pubmed
,
Xenbase
D'Amati,
Altered distribution of desmin filaments in hypertrophic cardiomyopathy: an immunohistochemical study.
1992,
Pubmed
Dent,
Host cell factors controlling vimentin organization in the Xenopus oocyte.
1992,
Pubmed
,
Xenbase
Dent,
A whole-mount immunocytochemical analysis of the expression of the intermediate filament protein vimentin in Xenopus.
1989,
Pubmed
,
Xenbase
Dunia,
Plasma membrane-cytoskeleton damage in eye lenses of transgenic mice expressing desmin.
1990,
Pubmed
Edström,
A new type of hereditary distal myopathy with characteristic sarcoplasmic bodies and intermediate (skeletin) filaments.
1980,
Pubmed
Evans,
The intermediate-filament proteins vimentin and desmin are phosphorylated in specific domains.
1988,
Pubmed
Eyer,
Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein.
1994,
Pubmed
Fidzianska,
Mallory body-like inclusions in a hereditary congenital neuromuscular disease.
1983,
Pubmed
Gard,
The synthesis and distribution of desmin and vimentin during myogenesis in vitro.
1980,
Pubmed
Geisler,
Phosphorylation of desmin in vitro inhibits formation of intermediate filaments; identification of three kinase A sites in the aminoterminal head domain.
1988,
Pubmed
Geisler,
Phosphorylation in vitro of vimentin by protein kinases A and C is restricted to the head domain. Identification of the phosphoserine sites and their influence on filament formation.
1989,
Pubmed
Gill,
Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit.
1990,
Pubmed
Goebel,
Desmin pathology in neuromuscular diseases.
1993,
Pubmed
Granger,
Desmin and vimentin coexist at the periphery of the myofibril Z disc.
1979,
Pubmed
Halbig,
Spheroid-cytoplasmic complexes in a congenital myopathy.
1991,
Pubmed
Hemsley,
A simple method for site-directed mutagenesis using the polymerase chain reaction.
1989,
Pubmed
Herrmann,
Temperature-sensitive intermediate filament assembly. Alternative structures of Xenopus laevis vimentin in vitro and in vivo.
1993,
Pubmed
,
Xenbase
Herrmann,
Expression of intermediate filament proteins during development of Xenopus laevis. II. Identification and molecular characterization of desmin.
1989,
Pubmed
,
Xenbase
Herrmann,
Expression of intermediate filament proteins during development of Xenopus laevis. I. cDNA clones encoding different forms of vimentin.
1989,
Pubmed
,
Xenbase
Hoffmann,
Amino acid sequence microheterogeneities of basic (type II) cytokeratins of Xenopus laevis epidermis and evolutionary conservativity of helical and non-helical domains.
1985,
Pubmed
,
Xenbase
Holtzer,
Intermediate-size filaments: changes in synthesis and distribution in cells of the myogenic and neurogenic lineages.
1982,
Pubmed
Klymkowsky,
Evidence that the deep keratin filament systems of the Xenopus embryo act to ensure normal gastrulation.
1992,
Pubmed
,
Xenbase
Klymkowsky,
Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody.
1981,
Pubmed
Klymkowsky,
Whole-mount staining of Xenopus and other vertebrates.
1991,
Pubmed
,
Xenbase
Lazarides,
Intermediate filaments as mechanical integrators of cellular space.
1980,
Pubmed
Lee,
Neurofilaments are obligate heteropolymers in vivo.
1993,
Pubmed
Ohara,
Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene.
1993,
Pubmed
Pellissier,
Myopathy associated with desmin type intermediate filaments. An immunoelectron microscopic study.
1989,
Pubmed
Porte,
Unusual familial cardiomyopathy with storage of intermediate filaments in the cardiac muscular cells.
1980,
Pubmed
Quinlan,
Heteropolymer filaments of vimentin and desmin in vascular smooth muscle tissue and cultured baby hamster kidney cells demonstrated by chemical crosslinking.
1982,
Pubmed
Sakakibara,
Idiopathic postpartum cardiomyopathy: report of a case with special reference to its ultrastructural changes in the myocardium as studies by endomyocardial biopsy.
1970,
Pubmed
Sarnat,
Vimentin/desmin immunoreactivity of myofibres in developmental myopathies.
1991,
Pubmed
Sarnat,
Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle.
1990,
Pubmed
Sarnat,
Vimentin and desmin in maturing skeletal muscle and developmental myopathies.
1992,
Pubmed
Sarria,
Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network.
1990,
Pubmed
Sarria,
A functional role for vimentin intermediate filaments in the metabolism of lipoprotein-derived cholesterol in human SW-13 cells.
1992,
Pubmed
Sejersen,
Transient expression of the intermediate filament nestin during skeletal muscle development.
1993,
Pubmed
Shafig,
Skeletal muscle in idiopathic cardiomyopathy.
1972,
Pubmed
Smith,
Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center.
1991,
Pubmed
,
Xenbase
Steinert,
In vitro assembly of homopolymer and copolymer filaments from intermediate filament subunits of muscle and fibroblastic cells.
1981,
Pubmed
Takebe,
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
1988,
Pubmed
Telerman-Toppet,
Auriculo-ventricular block and distal myopathy with rimmed vacuoles and desmin storage.
1991,
Pubmed
Tidball,
Desmin at myotendinous junctions.
1992,
Pubmed
Tokuyasu,
Distributions of vimentin and desmin in developing chick myotubes in vivo. II. Immunoelectron microscopic study.
1985,
Pubmed
van de Klundert,
Intermediate filaments: regulation of gene expression and assembly.
1993,
Pubmed
Vize,
Assays for gene function in developing Xenopus embryos.
1991,
Pubmed
,
Xenbase
Vogelstein,
Preparative and analytical purification of DNA from agarose.
1979,
Pubmed
Wong,
Characterization of dominant and recessive assembly-defective mutations in mouse neurofilament NF-M.
1990,
Pubmed
Xu,
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.
1993,
Pubmed
